KCT0000422招募中未知
Phase II multicenter study of Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma: toxicity and outcome
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 入组人数
- 71
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional Study
入排标准
- 年龄范围
- 18(Year) 至 o Limit（—）
- 性别
- All
入选标准
- •1. Male or female patients = 18 years of age
- •2. Intitially diagnosed or recurrent hepatocellular carcinoma (HCC)
- •3. Unresectable HCC
- •4. Cirrhotic status of Child Pugh class A or B7
- •5. Eastern Cooerative Oncology Group performance status 0 or 1
- •6. Tumor size < 10cm
- •7. The volume of uninvolved must be at least 1000 ml
- •8. Incomplete response after trans-arterial chemo-embolization of 1-5
- •9. A single lesion or multiple lesions including portal vein tumor thrombosis included in radiation field with one or consecutive sesseions of SBRT
- •10. No evidence of an uncontrolled lesion at any other site
- •11. No evidence of complications of liver cirrhosis
- •12. No evidence of uncontrolled inter-current illness
- •13. Patient or gaurdian must be able to provide verbal and written informed consent
排除标准
- •1. Patient with previous history of abdominal radiation
- •2. Direc invasion to esophagus, stomach or colon by HCC
研究者
相似试验
进行中（未招募）
1 期
Prostate cancer with OligometaSTatic relapse: Combining stereotactic Ablative Radiotherapy and Durvalumab (MEDI4736), a randomized phase II trialCTIS2024-513207-13-00Institut De Cancerologie De L Ouest96
已完成
2 期
Prospective phase II study of stereotactic body radiation therapy using helical tomotherapy for stage IA non-small cell lung cancer.stage IA non-small cell lung cancerJPRN-UMIN000001721Aichi Cancer Center Hospital50
进行中（未招募）
1 期
A phase 2 trial for patients with metastatic prostate cancer to study treatment with nivolumab and ipilimumab with or without radiotherapymetastatic castration-resistant prostate cancerMedDRA version: 21.1Level: PTClassification code 10036909Term: Prostate cancer metastaticSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 21.0Level: PTClassification code 10036920Term: Prostate cancer stage IVSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 21.1Level: LLTClassification code 10076506Term: Castration-resistant prostate cancerSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2018-003461-34-DKDepartment of Oncology, Herlev & Gentofte Hospital90
已完成
1 期
A phase I clinical trial of stereotactic body radiotherapy for patients with cervical cancer unsuitable for intracavitary brachytherapyCervical cancerJPRN-UMIN000020519Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital12
已完成
2 期
Multicenter prospective study of stereotactic body radiotherapy for untreated solitary primary hepatocellular carcinomantreated solitary primary hepatocellular carcinomaJPRN-UMIN000013011STRSPH study group36